Summary
Overview
Work History
Education
Skills
Additional Information
Timeline
Generic

Michael F. Forte

Doylestown,PA

Summary

Results-oriented Clinical Research Executive, experienced in leading commercial operations and recognized for achieving significant growth and enhancing operational efficienProven expertise in strategic planning, sales team leadership, and innovative problem-solving.ing. Instrumental in aligning cross-functional and therapeutically focused project teams to meet organizational financial targets.

Overview

37
37
years of professional experience

Work History

Executive Director Business Development – Early Phase

Worldwide Clinical Trials
Research Triangle Park, NC
01.2024 - Current
  • Manage an early-phase business development team while coordinating efforts with marketing, operations, and scientific affairs.
  • Led successful 2024 sales, meeting 90% of target in clinic deals in a challenging market.
  • As a member of Early Phase Leadership, supports a cross-functional, therapeutically focused expansion within Ph I clinical development, reflecting market trends.

Vice President Sales – North America

Veristat
Southborough, MA
03.2022 - 12.2023
  • Managed a North American sales team to achieve sales goals, selling full CRO services and standalone Biometrics and Regulatory Services.
  • Key role in recruitment, development, and motivation of sales team to achieve performance targets.
  • Coordinated commercial initiatives across Europe and APAC as part of the Senior Leadership Team.

Senior Vice President Global Sales and Marketing

Clinlogix
Springhouse, PA
04.2020 - 01.2022
  • Reporting to the CEO, supervised global commercial and marketing departments within a full-spectrum Medical Device CRO with annual earnings surpassing $60M.
  • Played critical role in the management of key accounts and participation within the Emerging Medtech Investment Community
  • Crucial participant in the development and execution of strategic plans, resulting in the company's acquisition by NAMSA.

Executive Director - North America

KCR, US
Boston, MA
03.2017 - 03.2020
  • Reporting into the CEO, KCR,SA, initiated and managed the establishment of KCR’s presence in the North American market based out of Boston.
  • Responsible for accelerated U.S. sales expansion, increasing annual sales from less than $20 million to surpassing $100 million within three years.
  • Linked KCR to Boston's financial, biotech, and educational sectors.
  • Enhanced trial execution solutions for KCR's Global Clinical Operations teams.
  • Chaired the CRO/CMO Committee at MassBio to drive impactful initiatives.

Consultant

Forte and Associates, LLC
Doylestown, PA
05.2009 - 03.2017
  • Facilitated market development efforts alongside marketing and clinical projects.
  • Leveraged expertise at organizations including Harvard Clinical Research Institute, CliniLabs, ClinPro, Discovery Labs, and Robard Inc.

Executive Director

Flagship Global Healthcare - Hedgeworth Capital
New York, NY
05.2007 - 04.2009
  • Supported this VC in entering an emerging Chinese market.
  • Built FGH Clinical Research network comprising over 1,200 investigators and research sites.
  • Secured additional $12.0M funding in China

Executive Vice President

Advanced Biologics
New Hope, PA
05.1995 - 04.2007
  • Contributed to launch, expansion phases, and final sale transaction of a comprehensive Phase II-IV clinical research and communications organization.
  • Led sales initiatives as player-coach, driving key account penetration and achieving double-digit growth.
  • Oversaw commercial strategy implementation to enhance profitability in service operations.
  • Supported operational integration leading to acquisition by INC Research (Syneos).

Director Global Marketing - Cardiovasculars

Bristol Myers Squibb
Princeton, NJ
09.1991 - 04.1995
  • Developed and executed franchise sales and marketing strategies for Cardiovascular and Infectious Diseases portfolios at BMS.
  • Provided support to Diagnostics and Diabetes Care teams.

Manager Clinical Research Cardiometabolic

Bristol Myers Squibb
Princeton, NJ
05.1988 - 09.1991
  • Managed the Cardiometabolic HMG-CoA Reductase clinical development program.
  • Supported the Infectious Disease Beta-lactamase Inhibitors clinical development program

Education

Bachelor of Science - Biochemistry

East Carolina University
Greenville, NC

Master of Science - Biochemistry

Medical College of Pennsylvania (Drexel)/Bryn Mawr College
Philadelphia, PA

Marketing

Temple University
Philadelphia, PA

Skills

  • CRO Marketing and Sales Expertise
  • High-Performance Team Leadership
  • Entrepreneurial mindset and innovative thinking
  • Cross-functional and therapeutic experience including Cardiometabolic, CNS, Oncology, and Rare and Inflammatory Diseases
  • Proficient in driving complex deal negotiations, budgeting, and financial oversight
  • Change Implementation and Process Optimization

Additional Information

Past Chair: MassBio CMO/CRO Committee

Research - Lipid/Sterol Interactions in Atherosclerosis

Member of the Swan Creek Rowing Club, Private Pilot, and Family Man

Timeline

Executive Director Business Development – Early Phase

Worldwide Clinical Trials
01.2024 - Current

Vice President Sales – North America

Veristat
03.2022 - 12.2023

Senior Vice President Global Sales and Marketing

Clinlogix
04.2020 - 01.2022

Executive Director - North America

KCR, US
03.2017 - 03.2020

Consultant

Forte and Associates, LLC
05.2009 - 03.2017

Executive Director

Flagship Global Healthcare - Hedgeworth Capital
05.2007 - 04.2009

Executive Vice President

Advanced Biologics
05.1995 - 04.2007

Director Global Marketing - Cardiovasculars

Bristol Myers Squibb
09.1991 - 04.1995

Manager Clinical Research Cardiometabolic

Bristol Myers Squibb
05.1988 - 09.1991

Bachelor of Science - Biochemistry

East Carolina University

Master of Science - Biochemistry

Medical College of Pennsylvania (Drexel)/Bryn Mawr College

Marketing

Temple University
Michael F. Forte